Merck (MRK) – Hot FDA News
-
Merck (MRK) Receives CRL for Gefapixant
-
Merck's (MRK) KEYTRUDA plus chemo 'significantly' improves overall survival in binary tract cancer
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to MRK Stock Lookup